Evaluation of the airborne particles fraction responsible for adverse health effects

Aerosol and Air Quality Research

Volumn 13, Issue 6, 2013, Pages 1678-1692

  Gorbunov, Boris ^a   Muir, Robert ^a   Jackson, Philip ^b   Priest, Nicholas D ^c  

^a Naneum CIC   (United Kingdom)

^b CERAM   (United Kingdom)

^c ATOMIC ENERGY OF CANADA LIMITED   (Canada)

Author keywords

Exposure; Lead; Lung deposition; Nanoparticles

Indexed keywords

ACTUAL MEASUREMENTS; ADVERSE HEALTH EFFECTS; AEROSOL PARTICLE SIZES; AEROSOL SIZE DISTRIBUTIONS; DEPOSITION EFFICIENCIES; EXPOSURE; LUNG DEPOSITIONS; PARTICLE DEPOSITIONS;

AEROSOLS; BLOOD; DEPOSITION; GLASS INDUSTRY; LEAD; NANOPARTICLES; RESPIRATORY SYSTEM; SIZE DISTRIBUTION;

HEALTH;

AEROSOL; BLOOD; HEALTH IMPACT; HEALTH RISK; LEAD; OCCUPATIONAL EXPOSURE; PARTICLE SIZE; POLLUTION EXPOSURE; RESPIRATORY DISEASE; SECONDARY SECTOR INDUSTRY; SIZE DISTRIBUTION; WORKPLACE;

EID: 84888423175     PISSN: 16808584     EISSN: 20711409     Source Type: Journal    
DOI: 10.4209/aaqr.2013.02.0039     Document Type: Article

References (40)

1. Anjilvel, S. and Asgharian, B. (1995). A Multiple-Path Model of Particle Deposition in the Rat Lung. Fundam. Appl. Toxicol. 28: 41-50.
2. Asgharian, B., Hofmann, W. and Bergmann, R. (2001). Particle Deposition in a Multiple-Path Model of the Human Lung. Aerosol Sci. Technol. 34: 332-339.
3. Baron, P.A. and Willeke, K. (2001). Aerosol Measurement. Principles, Techniques and Applications. J. Wiley and sons, p. 1131.
4. Brown, J.S., Zeman, K.L. and Bennett, W.D. (2002). Ultrafine Particle Deposition and Clearance in the Healthy and Obstructed Lung. Am. J. Respir. Crit. Care Med. 166: 1240-1247.
5. Chamberlain, A.C. (1985). Prediction of Response of Blood Lead to Airborne and Dietary Lead from Volunteer Experiments with Lead Isotopes. Proc. R. Soc. London, Ser. B 224: 149-182.
6. Dockery, D.W., Pope, C.A., Xu, X., Spengler, J.D., Ware, J.H., Fay, M.E., Ferris, B.G. and Speizer, F.E. (1993). An Association between Air Pollution and Mortality in Six US Cities. New Engl. J. Med. 329: 1753-1759.
7. Donaldson, K., Li, X.Y. and MacNee, W. (1998). Ultrafine (Nanometer) Particle-Mediated Lung Injury. J. Aerosol Sci. 29: 553-60.
8. Ferin, J., Oberdorster, G. and Penny, D.P. (1992). Pulmonary Retention of Ultrafine and Fine Particle in Rats. Am. J. Respir. Cell Mol. Biol. 6: 535-542.
9. Ferin, J. (1994). Pulmonary Retention and Clearance of Particles. Toxicol. Lett. 72: 121-125.
10. Finlay, W.H. and Martin, A.R. (2008). Recent Advances in of Predictive Understanding of Respiratory Tract Deposition. J. Aerosol Med. Pulm. Drug Deliv. 21: 189-205.
11. Gnewuch, H., Muir, R., Gorbunov, B., Priest, N.D. and Jackson, P.R. (2009). A Novel Size-Selective Airborne Particle Sampling Instrument (WRAS) for Health Risk Evaluation, In Nanomaterials: Risk and Benefits. Linkov, I. and Steevens, J. (Eds.), Springer, The Netherlands, p. 225-233.
12. Gorbunov, B., Priest, N.D., Muir, R.B., Jackson, P.R. and Gnewuch, H. (2009). A Novel Size-Selective Airborne Particle Size Fractionating Instrument for Health Risk Evaluation. Ann. Occup. Hyg. 53: 225-237.
13. Gorbunov, B., Muir, R., Bello, D., Gnewuch, H., LeCloux, A., Luizi, F., Del Tedesco, M. and Green, D. (2010) Exposure - Dose Relationship for Airborne Nanoparticles. In Advances in Environmental Research, Volume 4, Daniels, J.A. (Ed.), Nova Publishes.
14. Griffin, T.B., Coulston, F., Wells, H., Russell, J.C. and Knelson, J.H. (1975). Clinical Studies of Men Continuously Exposed to Airborne Particulate Lead. In Lead, Griffin, T.B. and Knelson, J.H. (Eds.), Acad. Press, N.Y., p. 221-239.
15. Gross S.B. (1981). Human oral and Inhalation Exposures to Lead: Summary of Kehoe Balance Experiments. J. Toxicol. Environ. Health 8: 333-377.
16. Hinds, W.C. (1999). Aerosol Technology. Properties, Behaviour and Measurement of Airborne Particles. J. Wiley and Sons, N.Y., p. 233-259.
17. Holbrook, L.T. and Longest, P.W. (2013). Validating CFD Predictions of Highly Localized Aerosol Deposition in Airway Models: In Vitro Data and Effects of Surface Properties. J. Aerosol Sci. 59: 6-21.
18. ICRP - International Commission on Radiological Protection (1975). Report of Task Group on Reference Man/ Oxford: Pergamon Press.
19. ICRP (1994). International Commission on Radiological Protection. Human Respiratory Tract Model for Radiological Protection. Annals of the ICRP, Publication 66, Tarrytown, Elsevier Science Inc., N.Y.
20. Jaques, P.A. and Kim, C.S. (2000). Measurement of Total Lung Deposition of Inhaled Ultrafine Particles in Healthy Men and Women. Inhalation Toxicol. 12: 715-731.
21. John, W. (2001). Size Distribution Characteristics of Aerosols, In Aerosol Measurement. Principles, Techniques and Applications, Baron, P.A. and Willeke, K. (Eds.), J. Wiley and Sons, N.Y., p. 99-116.
22. Kleinstreuer, C., Zhang, Z. and Li, Z. (2008). Modelling Airflow and Particle Transport/Deposition in pulmonary Airways. Respir. Physiol. Neurobiol. 163: 128-138.
23. Koch, W. and Stöber, W. (2001). A Simple Pulmonary Retention Model Accounting for Dissolution and Macrophage-Mediated Removal of Deposited Polydisperse Particles. Inhalation Toxicol. 13: 129-148.
24. Larson, R.R., Story, S.G. and Hegmann, K.T. (2010). Assessing the Solubility of Silicon Dioxide Particles Using Simulated Lung Fluid. Open Toxicol. J. 4: 51-55.
25. Leggett, R.W. (1993). An Age-Specific Kinetic Model of Lead Metabolism in Humans. Environ. Health Perspect. 101: 598-616.
26. Lippmann, M. (1995) Size-selective health hazard Sampling, In Air Sampling Instruments for Evaluation of Atmospheric Contaminants, 8th Ed., ACGIH, Cincinnati.
27. Nemmar, A, Hoet, P.H.M., Vanquickenborne, B., Dinsdale, D., Thomeer, M., Hoylaerts, M.F., Vanbilloen, H., Mortelmans, L. and Nemery, B. (2002). Passage of Inhaled Particles into the Blood Circulation in Humans. Circulation 105: 411-414.
28. Oberdorster, G., Ferin, J. and Lehnert, B.E. (1994). Correlation between Particle-Size, in-Vivo Particle Persistence, and Lung Injury. Environ Health Perspect. 102: 173-179.
29. O'Flaherty, E.J. (1993). Physiologically Based Models for Bone-Seeking Elements. Toxicol. Appl. Pharmacol. 118: 16-29.
30. Peters, A., Wichmann, H.E., Tuch, T., Heinrich, J. and Heyder, J. (1997). Respiratory Effects are Associated with the Number of Ultrafine Particles. Am. J. Respir. Crit. Care Med. 155: 1376-1383.
31. Phalen, R.F., Oldham, M.J. and Nel, A.E. (2006) Tracheobronchial Particle Dose Concentrations for in Vitro Toxicology Studies. Toxicol. Sci. 92: 126-132.
32. Pope, C.A., Dockery D.W. and Schwartz, J. (1995). Review of Epidemiological Evidence of Health Effects of Particulate Air Pollution. Inhalation Toxicol. 7: 1-18.
33. Rabinowitz, M.B., Wetherill, G.W. and Kopple, J.D. (1976). Kinetic Analysis of Lead Metabolism in Healthy Humans. J. Clin. Invest. 58: 260-270.
34. Schiller, C.F., Gebhart, J., Heyder, J., Rudolf, G. and Stahlhofen, W. (1988). Deposition of Monodisperse Insoluble Aerosol Particles in the 0.005 to 0.2 μm Size Range within the Human Respiratory Tract. Ann. Occup. Hyg. 32: 41-49.
35. Seaton, A., MacNee, W., Donaldson, K. and Godden, D. (1995). Particulate Air Pollution and Acute Health Effects. Lancet 345: 176-178.
36. Tsai, C.J., Shih, T.S. and Sheu, R.N. (1997). Characteristics of Lead Aerosols in Different Work Environments. Am. Ind. Hyg. Assoc. J. 58: 650-656.
37. Whitby, K.T. (1978). The Physical Characteristics of Sulphur Aerosols. Atmos. Environ. 12: 135-159.
38. Wilson, F.J.Jr., Hiller, F.C., Wilson, J.D. and Bone, R.C. (1985). Quantitative Deposition of Ultrafine Stable Particles in the Human Respiratory Tract. J. Appl. Physiol. 58: 223-229.
39. Xi, J. and Longest, P.W. (2008). Evaluation of a Novel Drift Flux Model for Stimulating Sub-Micrometer Aerosol Dynamics in Human Upper Tracheobronchial Airways. Ann. Biomed. Eng. 36: 1714-1734.
40. Yeh, H.C., Cuddihy, R.G., Phalen, R.F. and Chang, I.Y. (1996). Comparisons of Calculated Respiratory Tract Deposition of Particles Based on the Proposed NCRP Model and the New ICRP Model. Aerosol Sci. Technol. 25: 134-140.